Moxonidine Effects on Neuropeptide Y

NCT05147753 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Hypertension

Interventions

DRUG: Moxonidine

Sponsor

Aristotle University Of Thessaloniki